Librax (Chlordiazepoxide, Clidinium Bromide)

Chlordiazepoxide and Clidinium bromide, the active ingredients in Librax, are a benzodiazepine and an anticholinergic presented as a 5 mg/2.5 mg oral tablet for oral use. They treat anxiety disorders and gastrointestinal spasm in adults. GNH USA supplies Librax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Librax acts on central nervous system anxiety pathways and gastrointestinal smooth‑muscle tone, providing relief in several conditions. - Anxiety disorders: reduces excessive worry and tension. - Irritable bowel syndrome: eases abdominal cramping and discomfort. - Peptic ulcer disease: diminishes ulcer‑related pain and spasms. - Gastrointestinal spasm: relaxes smooth‑muscle contractions in the gut.

Librax may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Drowsiness: feeling unusually sleepy. - Dry mouth: reduced salivation leading to throat discomfort. - Constipation: infrequent or hard stools. - Dizziness: sensation of light‑headedness.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing that may require medical attention. - Severe hypotension: marked drop in blood pressure. - Paradoxical agitation: unexpected increase in anxiety or aggression. - Dependence or withdrawal: physical reliance with potential withdrawal symptoms upon cessation. - Anaphylaxis: severe allergic reaction with rash, swelling, and breathing difficulty.

Before prescribing Librax, clinicians should consider several safety factors. - Avoid alcohol: concurrent use can intensify sedation and respiratory effects. - Use caution in elderly: increased sensitivity to CNS depression and anticholinergic effects. - Monitor liver function: both components are metabolised hepatically. - Assess substance‑use history: risk of dependence with benzodiazepine component. - Pregnancy category D: only if benefits outweigh risks; avoid during breastfeeding. - Store at ambient temperature below 25°C: keep in original pack, protect from moisture.

Librax can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Alcohol: additive CNS depression. - Opioids: heightened risk of respiratory depression and sedation. - Other CNS depressants (e.g., barbiturates, antihistamines): may cause profound sedation.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may increase clidinium levels. - Anticholinergic agents (e.g., atropine): can enhance anticholinergic side effects. - Antidepressants (SSRIs, SNRIs): may increase risk of serotonin syndrome when combined with benzodiazepines.